Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-26-012837

Options or other derivatives

  • CEO acquired 0 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pershing Edward CEO 2026-03-25 Grant or award · 8% Unsecured Convertible Promissory Note +0 D
Loading xslF345X06/ownership.xml…